X T L Biopharmaceuticals Ltd (XTLB) Technical Analysis
$0.58
Market is closed - opens 7 PM, 23 Mar 2026
Insights
- X T L Biopharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for X T L Biopharmaceuticals stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, X T L Biopharmaceuticals stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for X T L Biopharmaceuticals stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 32.05 | Neutral |
Stochastic | 15.33, 16.09 | Neutral |
Ultimate Oscillator | 49.62 | Neutral |
Stochastic Relative Strength Index | 6.59, 10.64 | Neutral |
Moving Average Convergence Divergence | -0.07, -0.06 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.62 | Sell |
20 | 0.7 | Sell |
50 | 0.83 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.63 | Sell |
20 | 0.69 | Sell |
50 | 0.78 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.62 | Sell |
20 | 0.7 | Sell |
50 | 1.05 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.57 | Sell |
20 | 0.6 | Sell |
50 | 0.68 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.58 | Buy |
20 | 0.56 | Sell |
50 | 0.65 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 0.63 |
Resistance L2 | 0.62 |
Resistance L1 | 0.6 |
Pivot Point | 0.6 |
Support L1 | 0.58 |
Support L2 | 0.58 |
Support L3 | 0.56 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.